Evaluation of the ECV304 spontaneously transformed HUVEC cell line for adhesion molecule research.
Stannard
A K
AK
Royal Free Hospital School of Medicine, University Department of Medicine, London, U.K.
Bradley
N J
NJ
Owen
J S
JS
D018952:Antigens, CD34 / Q000096:biosynthesis; D015415:Biomarkers; D002448:Cell Adhesion / Q000187:drug effects; D015815:Cell Adhesion Molecules / Q000096:biosynthesis*; D002461:Cell Line, Transformed; D019040:E-Selectin / Q000096:biosynthesis; D004730:Endothelium, Vascular / Q000166:cytology* / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D007150:Immunohistochemistry; D018799:Intercellular Adhesion Molecule-1 / Q000096:biosynthesis; D008070:Lipopolysaccharides / Q000494:pharmacology; D019408:Platelet Endothelial Cell Adhesion Molecule-1 / Q000096:biosynthesis; D018180:Thrombomodulin / Q000096:biosynthesis; D014471:Umbilical Veins; D019010:Vascular Cell Adhesion Molecule-1 / Q000096:biosynthesis; D014841:von Willebrand Factor / Q000096:biosynthesis
D018952:Antigens, CD34; D015415:Biomarkers; D015815:Cell Adhesion Molecules; D019040:E-Selectin; D008070:Lipopolysaccharides; D019408:Platelet Endothelial Cell Adhesion Molecule-1; D018180:Thrombomodulin; D019010:Vascular Cell Adhesion Molecule-1; D014841:von Willebrand Factor; D018799:Intercellular Adhesion Molecule-1